Derek M Meisner, the Chief Legal Officer & Corp Sec of $ABOS ($ABOS), sold 11,122 shares of the company on 01-03-2025. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.2% of their shares. Following this trade, they now own 97,745 shares of $ABOS stock.
$ABOS Insider Trading Activity
$ABOS insiders have traded $ABOS stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABOS stock by insiders over the last 6 months:
- DEREK M MEISNER (Chief Legal Officer & Corp Sec) sold 11,122 shares.
- RUSSELL BARTON (Chief Operating Officer) sold 7,636 shares.
- MATT ZUGA (CFO & Chief Business Officer) sold 13,235 shares.
- ERIC SIEMERS (Chief Medical Officer) sold 10,859 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABOS Hedge Fund Activity
We have seen 34 institutional investors add shares of $ABOS stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LAURION CAPITAL MANAGEMENT LP removed 311,292 shares (-26.4%) from their portfolio in Q3 2024
- NORTHERN TRUST CORP added 238,762 shares (+340.7%) to their portfolio in Q3 2024
- PRICE T ROWE ASSOCIATES INC /MD/ removed 196,745 shares (-18.8%) from their portfolio in Q3 2024
- FRANKLIN RESOURCES INC added 181,451 shares (+5.4%) to their portfolio in Q3 2024
- BLACKROCK, INC. added 172,869 shares (+8.0%) to their portfolio in Q3 2024
- MORGAN STANLEY added 151,391 shares (+172.4%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 119,332 shares (-6.1%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
